COCAETHYLENE IS MORE POTENT THAN COCAINE IN MEDIATING LETHALITY

被引:169
作者
HEARN, WL
ROSE, S
WAGNER, J
CIARLEGLIO, A
MASH, DC
机构
[1] UNIV MIAMI,SCH MED,DEPT PHARMACOL,MIAMI,FL 33152
[2] UNIV MIAMI,SCH MED,COMPREHENS DRUG RES CTR,MIAMI,FL 33152
[3] UNIV MIAMI,SCH MED,DEPT NEUROL,MIAMI,FL 33152
[4] UNIV MIAMI,SCH MED,DIV VET RESOURCES,MIAMI,FL 33152
关键词
COCAETHYLENE; TOXICITY; LD50; MICE; COCAINE; ALCOHOL;
D O I
10.1016/0091-3057(91)90222-N
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Cocaethylene is a pharmacologically active cocaine metabolite that is formed in the presence of ethanol by the activity of liver enzymes. The pharmacology of cocaethylene has not been extensively investigated and its acute toxicity is unknown. The acute toxicity of cocaethylene was compared to cocaine in Swiss-Webster mice. The LD50 of cocaethylene was 60.7 mg/kg and 63.8 mg/kg in female and male mice, respectively. In comparison, the LD50 of cocaine was 93.0 mg/kg in both female and male mice. These studies demonstrate that the cocaine-alcohol metabolite, cocathylene, is more potent in mediating lethality than the parent drug.
引用
收藏
页码:531 / 533
页数:3
相关论文
共 16 条
  • [1] COMPARATIVE LETHALITY OF COCA AND COCAINE
    BEDFORD, JA
    TURNER, CE
    ELSOHLY, HN
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1982, 17 (05) : 1087 - 1088
  • [2] L(+)-2-Tropinone
    Bell, M. R.
    Archer, S.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1960, 82 (17) : 4642 - 4644
  • [3] BLISS CI, 1983, Q J PHARM PHARMACOL, V11, P192
  • [4] DEJONG AWK, 1947, RECL TRAV CHIM PAY B, V66, P544
  • [5] COCAETHYLENE - A UNIQUE COCAINE METABOLITE DISPLAYS HIGH-AFFINITY FOR THE DOPAMINE TRANSPORTER
    HEARN, WL
    FLYNN, DD
    HIME, GW
    ROSE, S
    COFINO, JC
    MANTEROATIENZA, E
    WETLI, CV
    MASH, DC
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 56 (02) : 698 - 701
  • [6] Kreek M. J., 1984, ALCOHOLISM POLYDRUG
  • [7] LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
  • [8] MASH D C, 1990, Society for Neuroscience Abstracts, V16, P14
  • [9] MASH DC, 1991, COMM PROBLEMS DRUG D
  • [10] SHARKEY J, 1988, J PHARMACOL EXP THER, V246, P1048